May 26, 2022
The vice president of neuroscience at Sangamo Therapeutics discussed identifying novel capsids with improved neuronal transduction to the CNS.
July 01, 2021
The head of neuroscience at Sangamo Therapeutics discussed advances in understanding disease biology that allow for more specific gene targeting.
June 29, 2021
The head of neuroscience at Sangamo Therapeutics discussed the potential of ZFPs in central nervous system disorders.